Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1667-98-7

Post Buying Request

1667-98-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1667-98-7 Usage

Type

Synthetic compound

Derivative of

Estrone (a naturally occurring hormone in the human body)

Usage

Pharmaceutical research and drug development

Specific Applications

a. Hormone replacement therapies
b. Treatments for menopause and osteoporosis

Laboratory Use

Reference standard for analytical testing

Mechanism of Action

Binds to estrogen receptors in the body

Significance

Important tool for studying the effects of estrogen on various physiological processes

Role

Advancing understanding of estrogen-related biology and development of new medical treatments

Check Digit Verification of cas no

The CAS Registry Mumber 1667-98-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,6,6 and 7 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1667-98:
(6*1)+(5*6)+(4*6)+(3*7)+(2*9)+(1*8)=107
107 % 10 = 7
So 1667-98-7 is a valid CAS Registry Number.

1667-98-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-((8S,9S,13S,14S,17S)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl)ethanone

1.2 Other means of identification

Product number -
Other names 18a-methylestrone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1667-98-7 SDS

1667-98-7Relevant articles and documents

-

Bowers et al.

, (1962)

-

New estrogen receptor antagonists. 3,20-Dihydroxy-19-norpregna-1,3,5(10)-trienes: Synthesis, molecular modeling, and biological evaluation

Kuznetsov, Yury V.,Levina, Inna S.,Scherbakov, Alexander M.,Andreeva, Olga E.,Fedyushkina, Irina V.,Dmitrenok, Andrey S.,Shashkov, Alexander S.,Zavarzin, Igor V.

, p. 670 - 682 (2017/12/08)

New estrogen receptor α (ERα) antagonists – 3,20-dihydroxy-19-norpregna-1,3,5(10)-trienes containing an additional carbocyclic ring D′ at the 16α,17α positions – were synthesized. The effects of the new compounds on the MCF-7 breast cancer cells and ERα activation were investigated. All the steroids studied were synthesized starting from estrone methyl ether. The scaffold of compounds containing the six-membered ring D′ was constructed via the Diels–Alder reaction of butadiene with 3-methoxy-19-norpregna-1,3,5(10),16-tetraen-20-one 5. The hydrogenation of primary 16α,17α-cyclohexeno-adduct 7 followed by 3-demethylation (by HBr–AcOH) and reduction of 20-oxo group (by LiAlH4) or in one step by DIBAH gave target mono- and dihydroxy steroids 9–11. The Corey–Chaykovsky reaction of the same 3-methoxy-19-norpregna-1,3,5(10),16-tetraen-20-one 5 gave 16α,17α-methylene-substituted compound. The reaction of the latter with DIBAH immediately yielded 3,20-dihydroxy-16α,17α-methyleno-19-norpregna-1,3,5(10)-triene 13. The same procedures using 3-methoxy-19-norpregna-1,3,5(10),16-tetraen-20-one 5 produced corresponding 3,20-dihydroxy-16,17-19-norpregna-1,3,5(10)-triene 16 and 3,20-dihydroxy-19-norpregna-1,3,5(10),16-tetraene 17. All compounds were fully characterized by 1D and 2D NMR, HRMS, and X-ray diffraction. The molecular docking showed that the target compounds can bind to ER, their binding mode being similar to that of natural estradiol. 16α,17α-Methylene- or unsubstituted compounds exhibit the highest cytotoxicity against MCF-7 cells, being simultaneously relatively weak ERα inhibitors. 3,20-Dihydroxy steroids containing the six-membered ring D′ proved to be the most effective ERα inhibitors. These compounds displayed moderate cytotoxicity comparable of that of tamoxifen and showed no toxic effect on MCF-10A normal, nontumorigenic epithelial cells. The new ER antagonists were found to be good candidates for further testing as agents for the treatment and prevention of ERα-positive breast cancers.

Stereoelectronically Controlled, Thallium(III)-Mediated C-19 Degradation of 19-Hydroxy Steroids. An Expedient Route to Estrone and its Congeners via 19-Nor-10β-hydroxy Intermediates

Kocovsky, Pavel,Baines, Richard S.

, p. 5439 - 5444 (2007/10/02)

Estrone (8b) has been synthesized in four steps from 3β-acetoxy-19-hydroxyandrost-5-en-17-one (2b), readily available from an industrial precursor.A key feature of the strategy is a stereoelectronically controlled, Tl(III)-mediated degradation (2b -> 5b).Oppenauer oxidation of diol 6b, resulting from saponification of the acetate 5b, afforded the unsaturated 10β-hydroxy ketone 7b, acid treatment of which induced aromatization affording 8b.An alternative route including dehydration (5b -> 9b) followed by Oppenauer oxidation (10b -> 8b) gave comparable results.This strategy has first been developed with the aid of cholestane model compounds (2a -> 5a) and then successfully applied to the synthesis of analogues in the cholestane, androstane, and pregnane series to produce the corresponding 19-nor-10β-hydroxy derivatives 7a-d and A-aromatic steroids 8a-d.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1667-98-7